CVS Group PLC (DE:4C9)
FRANKFURT:4C9
4C9 Stock Chart & Stats
€14.50
-€0.20(-2.01%)
At close: 4:00 PM EST
€14.50
-€0.20(-2.01%)
Day’s Range― - ―
52-Week Range€12.60 - €17.40
Previous CloseN/A
Volume0.00
Average Volume (3M)99.00
Market Cap
€1.01B
Enterprise Value€1.22B
Total Cash (Recent Filing)€12.30M
Total Debt (Recent Filing)€358.60M
Price to Earnings (P/E)55.9
Beta0.81
Next Earnings
Sep 24, 2026EPS Estimate
0.54Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.22
Shares Outstanding69,967,155
10 Day Avg. Volume291
30 Day Avg. Volume99
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)2.99
Price to Sales (P/S)1.33
P/FCF Ratio16.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€19.30Price Target Upside33.13% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.01
Revenue Forecast (FY)€8.27M
Bulls Say, Bears Say
Bulls Say
Commercial InitiativesCVS Group's commercial initiatives, including booking tools and targeted campaigns, helped restore positive like-for-like growth and indicate scalable demand-generation capabilities.
Management GuidanceManagement's reiterated confidence that the like-for-like growth target range of four to eight percent remains achievable supports investor expectations for sustained operational improvement.
Pricing StrategyPlanned pricing actions are expected to contribute materially to the company's medium-term ambitions, bolstering margin prospects and revenue resilience.
Bears Say
Growth Trajectory RiskLike-for-like growth currently remains below the stated medium-term target range, placing pressure on the revenue trajectory until commercial and operational levers close the gap.
Partner Execution BurdenCMA-proposed remedies may place disproportionate burdens on independent partners, increasing execution complexity and potential integration costs across the CVS network.
Regulatory UncertaintyThe CMA investigation and its provisional decision create regulatory uncertainty that could limit CVS Group's strategic options and weaken its market position in the UK veterinary sector.
CVS Group plc News
4C9 FAQ
What was CVS Group PLC’s price range in the past 12 months?
CVS Group PLC lowest stock price was €12.60 and its highest was €17.40 in the past 12 months.
What is CVS Group PLC’s market cap?
CVS Group PLC’s market cap is €1.01B.
When is CVS Group PLC’s upcoming earnings report date?
CVS Group PLC’s upcoming earnings report date is Sep 24, 2026 which is in 108 days.
How were CVS Group PLC’s earnings last quarter?
CVS Group PLC released its earnings results on Feb 26, 2026. The company reported €0.465 earnings per share for the quarter, missing the consensus estimate of €0.503 by -€0.037.
Is CVS Group PLC overvalued?
According to Wall Street analysts CVS Group PLC’s price is currently Undervalued.
Does CVS Group PLC pay dividends?
CVS Group PLC does not currently pay dividends.
What is CVS Group PLC’s EPS estimate?
CVS Group PLC’s EPS estimate is 0.54.
How many shares outstanding does CVS Group PLC have?
CVS Group PLC has 69,967,155 shares outstanding.
What happened to CVS Group PLC’s price movement after its last earnings report?
CVS Group PLC reported an EPS of €0.465 in its last earnings report, missing expectations of €0.503. Following the earnings report the stock price went down -1.274%.
Which hedge fund is a major shareholder of CVS Group PLC?
Currently, no hedge funds are holding shares in DE:4C9
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CVS Group plc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€19.30 (33.13% Upside)
€19.30 (33.13% Upside)
Insider Transactions
Bought Shares
Worth €14.5K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
42.22%
12-Months-Change
Fundamentals
Return on Equity
5.35%
Trailing 12-Months
Asset Growth
2.97%
Trailing 12-Months
Company Description
CVS Group PLC
CVS Group plc engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail. It operates animal veterinary practices and complementary veterinary diagnostic businesses. The company also provides pet cremation and clinical waste services for veterinary practices. In addition, it operates Animed Direct, an online pharmacy and retail business that sells prescription and non-prescription medicines, premium pet foods, and other pet care products; and an online dispensary. Further, the company provides burial grounds; and veterinary instrumentation supply and referral services. It owns 506 veterinary practices, 3 laboratories, 7 crematoria, and an online pharmacy. CVS Group plc was founded in 1999 and is based in Diss, the United Kingdom.
4C9 Stock 12 Month Forecast
Average Price Target
€19.30
▲(33.13% Upside)
Technical Analysis
Options Prices
Currently, No data available
---